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ABSTRACT
Two synthetic tRNAs have been generated that can be
enzymatically aminoacylated with alanine and have
AAA anticodons to recognize a poly(U) template. One
of the tRNAs (tRNAe
Ala/AAA) is nearly identical to
Escherichia coli elongator tRNAAla. The other has a
sequence similar to Escherichia coli initiator tRNAMet
(tRNAjAla/AAA). Although both tRNAs can be used in
poly(U)-directed nonenzymatic initiation at 15 mM
Mg2 + , only the elongator tRNA can serve for peptide
elongation and polyalanine synthesis. Only the initiator
tRNA can be bound to 30S ribosomal subunits or 70S
ribosomes in the presence of initiation factor 2 (IF-2)
and low Mg2+ suggesting that it can function in
enzymatic peptide initiation. A derivative of coumarin
was covalently attached to the a amino group of alanine
of these two Ala-tRNA species. The fluorescence
spectra, quantum yield and anisotropy for the two Ala-
tRNA derivatives are different when they are bound to
70S ribosomes (nonenzymatically in the presence of 15
mM Mg2+) indicating that the local environment of the
probe is different. Also, the effect of erythromycin on
their fluorescence is quite different, suggesting that the
probes and presumably the alanine moiety to which
they are covalently linked are in different positions on
the ribosomes.
INTRODUCTION
Recombinant DNA techniques have been used to introduce
specific mutations into naturally occurring tRNAs. The mutant
tRNAs were expressed in E.coli and then isolated so that the roles
of specific bases and sequences in aminoacylation and peptide
synthesis could be examined (reviewed in 1,2). Recently,
adequate quantities of these recombinant tRNAs have been
produced by in vitro transcription (3) for use in in vitro studies.
Insight into the role of modified bases in tRNA structure (4,5),
aminoacylation (3) and the ability of tRNA to accurately
participate in peptide synthesis (6) has resulted.
Most studies examining the interactions of tRNAs with
ribosomes and the reactions that make up peptide elongation have
used filter binding assays or applied chemical modification of
the tRNA/rRNA followed by analysis of protected regions of the
RNA (reviewed in 7 and 8). Although effective and sensitive,
these methods require the disruption of ongoing biological
processes. An alternative method we have previously employed
in examining tRNA structure and function is fluorescence. This
technique was used to demonstrate a change in the conformation
of tRNAPhe upon deacylation during peptidyl transfer (9) and
movement of tRNAPhe relative to ribosomal protein LI upon
peptide bond formation (10). Fluorescent signals can be readily
followed throughout a series of reaction steps with little or no
perturbation of the ongoing reaction sequences.
We have previously reported the synthesis of polycysteine and
polyserine from a poly(U) template using novel tRNAcys/AAA
and tRNASer/AAA, respectively (11). By attaching a fluorescent
probe to the amino group of Phe-tRNA or the novel Ser-tRNA,
we were able to monitor the ribosomal environment surrounding
the amino terminus of the nascent peptides formed with these
synthetic tRNAs (11).
In order to further examine the initial steps of nascent peptide
formation and tRNA positioning on the ribosome, we have
generated two novel tRNAs that are enzymatically aminoacylated
with alanine and possess AAA anticodons (see Figure 1). The
first tRNA (tRNAjAla/AAA) is analogous to the E.coli initiator
tRNA^1 (12). Although the primary structure of this tRNA was
modified to facilitate in vitro transcription and aminoacylation,
the features believed to be necessary for initiator function were
maintained. These features include a non-Watson—Crick
base pair at the end of the acceptor stem (13,14), a
pyrimidine-ll-purine-24 base pair in the dihydrouridine stem
(12), and a series of guanine and cytosine residues in the
anticodon stem forming three consecutive G-C base pairs (13).
The second tRNA (tRNAeAla/AAA) was constructed to be
analogous to the E.coli elongator tRNAAla/UGC (12). Here we
report on the properties of the novel initiator tRNAiAla/AAA and
the elongator tRNA£
Ala/AAA with respect to in vitro translation.










5750 Nucleic Acids Research, Vol. 19, No. 20
MATERIALS AND METHODS
Materials
Oligodeoxyribonucleotides were synthesized on an Applied
Biosystems (Foster, CA) 381A DNA synthesizer. Plasmid
pUC18 was from Bethesda Research Laboratories (Gaithersburg,
MD), PCR reagents were from Perkin-Elmer Cetus (Norwalk,
CT) and the Sequenase II kit used for double-stranded sequencing
was from United States Biochemicals (Cleveland, OH).
[a-35S]dATP was from New England Nuclear (Boston, MA)
and [14C]phenylalanine and [14C]alanine were from ICN
Radiochemicals (Irvine, CA). 3-(4-maleimidophenyl)-7-diethyl-
amino-4-methylcoumarin (CPM) was from Molecular Probes
(Junction City, OR). Yeast tRNAphe was from Sigma Chemical
Company (St. Louis, MO). Purified Escherichia coli initiation
factor 2 (IF-2) was a generous gift from Dr. C.Gualerzi (Max-
Planck-Institut fur Molekulare Genetik, Berlin). The preparation
of Escherichia coli ribosomal subunits has been described before
(15). T7 RNA polymerase was prepared as described by
Davanloo et al. (16).
tRNA preparation and aminoacylation
Plasmids containing the synthetic elongator tRNA^ (pALA) or
synthetic initiator tRNAAla (pFMET) were constructed by
applying previously described PCR and recombinant DNA
strategies (11). The procedure used for in vitro transcription of
the tRNAs has been reported previously (11). The resulting
synthetic tRNAs (shown in cloverleaf form in Figure 1) were
enzymatically aminoacylated with [14C]alanine (50 Ci/mol)
using the aminoacyl-tRNA synthetases present in the 70%
saturated ammonium sulfate precipitate of a wheat germ S-150
fraction (17) as described previously for other synthetic tRNAs
(11). Aminoacylation of tRNA£
Ala/AAA routinely reached about
60% (pmol Ala incorporated/pmol tRNA) using the wheat germ
synthetases or the tRNA-depleted E.coli S-150 fraction as the
source of aminoacyl-tRNA synthetase. Aminoacylation of
tRNAiAla/AAA reached about 20% with either synthetase
preparation. In no case was either tRNA observed to be
aminoacylated with any amino acid other than alanine (data not
shown). Yeast tRNAphe was aminoacylated as described in
Picking et al. (18).




Labeling with CPM of a mercaptoacetic acid covalently linked
to the amino acid group of each of the two synthetic [14C]alanyl-
tRNAs was performed as described previously for natural (18)
and synthetic tRNAs (11). The CPM-Ala-tRNA was purified by
C| reversed-phase high performance liquid chromatography
essentially as described for CPM-Ser-tRNASer/AAA (11). The
[l4C]alanine concentration in the collected fractions was
determined by liquid scintillation spectrometry, tRNA
concentration was determined by absorbance at 260 nm (1 A260
= 1.5 nmol) and the CPM concentration was measured by
absorbance at 390 nm (eM = 30,000). Only CPM-Ala-tRNA
with a CPM: Ala:tRNA ratio of 1:1:1 was used in these studies.
Poly(U)-dependent polypeptide synthesis
Polypeptide synthesis was facilitated by prebinding N-acetyl
derivatives of Phe-tRNA, Ala-tRNAe
Ala/AAA and Ala-
tRNAjAla/AAA. N-acetylation of the aminoacyl-tRNAs was
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Figure 1. The nucleotide sequence of tRNA?
Ala/AAA and tRNAiAWAAA. The
sequence of the synthetic elongator tRNA and initiator tRNA are given in cloverleaf
form. Where sequence changes have been made to facilitate recognition of poly(U)
and aminoacylation with alanine, the original bases are shown underlined next
to the position they occupy in the natural tRNA. The circled A in tRNAiAla/AAA
was inserted to destroy an internal BstNI restriction site which prevented formation
of the full length DNA required for transcription with T7 polymerase. The addition
of the A also created a new Ncol restriction site which was used to screen isolated
plasmid inserts for the correct tRNA sequence.
according to the method of Rappoport and Lapidot (19).
Nonenzymatic tRNA binding to ribosomes was performed in 50
mM Tris-HCl (pH 7.5), 100 mM NH4C1, 15 mM Mg(OAc)2,
5 mM 2-mercaptoethanol, 0.2 mg/ml poly(U), 0.5 /tM ribosomes
and 0.5 /*M acylated tRNA. Polyalanine synthesis was initiated
as described previously for polyphenylalanine (18) and polyserine
(11) except that [14C]alanine and either tRNAe
Ala/AAA or
tRNAi
Ala/AAA were used as the amino acid and tRNA sources.
tRNAeAla/AAA was used at a final concentration of 1 A260
units/ml while tRNAjAla/AAA was used at a concentration of
about 3 A26o units/ml to reach nearly similar amounts of
aminoacylated tRNA in all polyalanine assays. The incorporation
of [l4C]alanine into polyalanine was determined as described
previously (11).
Determination of nascent peptide chain length
For estimation of the average length of nascent polyalanine chains
(given in Table II) it was necessary to experimentally determine
the number of active ribosomes in the poly(U)-dependent
polypeptide assay described above. To do this, 55 pmol of
Ac[l4C]Phe-tRNA (100 Ci/mol), Ac[14C]Ala-tRNAe
Ala/AAA or
Ac[I4C]Ala-tRNAi
Ala/AAA (50 Ci/mol) was prebound to poly(U)-
programmed ribosomes (50 pmol) by incubation at 37 °C for 15
min prior to the addition of the other components required for
protein synthesis. After prebinding the Ac[ l4C]aminoacyl-
tRNA, polypeptide synthesis was carried out using nonradioactive
alanine. This provides a measure of those ribosomes on which
the amino acid from prebound [14C]-labeled Ac-aa-tRNA was
subsequently incorporated into nascent polyalanine. When the
total pmol of alanine incorporated into polyalanine (described
above) is measured, the value can be divided by the number of
active ribosomes to give an estimate of the average nascent
polyalanine chain length.
Fluorescence measurements
A model 8000 photon-counting spectrofluorometer from SLM-
Aminco Instruments, Inc. (Urbana, IL) was used for steady-state
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1 Deacylated tRNAPhe was prebound to poly(U)-programmed ribosomes in a 1.1:1 ratio prior to the binding of the
fluorescent tRNA species.
were bound to ribosomes as described above except that the
concentration of these tRNAs was reduced to about 10% of the
ribosome concentration to ensure maximum tRNA binding.
Spectra were measured at 1 -nm emission intervals at a scanning
rate of 0.5 sec per wavelength increment with an excitation
wavelength of 385 nm. Anisotropy and relative intensity
measurements were carried out at an emission wavelength of 475
nm. Measurements were automatically corrected for the
wavelength dependence of photomultiplier sensitivity.
Fluorescence measurements were carried out at 20° C in a volume
of 0.6 ml. All measurements were made with a sample
absorbance of less than 0.1 at the excitation wavelength and
fluorescence anisotropy measurements were made as previously
described (18). The quantum yields of CPM-Ala-tRNAeAla/AAA
and CPM-Ala-tRNAiAla/AAA were determined by comparison
with quinine sulfate in 0.05 M H2SO4, which has a quantum
yield of 0.508 at 25°C (21).
tRNA binding to 30S and 70S ribsomes by IF-2
CPM-Ala-tRNAeAla/AAA and CPM-Ala-tRNAiAla/AAA (25 pmol)
were used to examine the effect IF-2 has on tRNA binding to
30S and 70S ribosomes. Fluorescence anisotropy and quantum
yield were measured in the presence and absence of purified IF-2
(105 pmol) after the sequential addition of 30S subunits (195
pmol) and 50S subunits (195 pmol). Measurements were taken
in 50 raM Tris-HCl (pH 7.5), 6 mM Mg(OAc)2, 50 mM
NH4C1, 1 mM GTP, 5 mM dithioerythritol and 0.2 mg/ml
poly(U) in a final volume of 600 /d. When these measurements
were finished, the Mg2+ concentration was raised to 15 mM to
nonenzymatically facilitate tRNA binding and the anisotropy and
quantum yield were measured again.
RESULTS
Fluorescence properties and binding to ribosomes of the
synthetic tRNAs
Synthetic initiator tRNAAla (tRNAiAla/AAA) and elongator
tRNAAla (tRNAeAla/AAA) were constructed; their sequences are
shown in the cloverleaf form (Figure 1). To monitor binding of
the synthetic tRNAs to the 70S ribosomes, each was fluorescently
labeled with CPM. The fluorescence anisotropy and quantum
yield were measured for each tRNA when free in solution, or
bound to the A and P site of 70S ribosomes, respectively (Table
I). Interestingly, these parameters differed for the two tRNAs
under the conditions examined. The anisotropy of free CPM-
Ala-tRNAe
Ala/AAA (0.185) was similar to that seen previously for
the natural elongator tRNA CPM-Phe-tRNAPhe (0.181) as well
as the synthetic elongator tRNA CPM-Ser-tRNASer/AAA (0.175).
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Figure 2. The poly(U)-directed synthesis of polyalanine with tRNAe
Ala'AAA.
AcPhe-tRNA (0.5 jtM) was prebound to poly(U)-programmed ribosomes (0.5
liM) to facilitate the synthesis of polyalanine with either 0.3 A260 of
tRNAiAla/AAA (open symbols) or 0.1 A26O tRNA,.
Ala/AAA (closed symbols) as the
elongator tRNA source in a final volume of 0.1 ml. [l4C]Alanine incorporation
was measured after incubation at 37°C for the times indicated by deacylating
all the aminoacylated tRNA with 0.5 M NaOH, then precipitating polyalanine
with 5 ml ice cold 10% trichloroacetic acid and determining the radioactivity
of the precipitate. Polyalanine synthesis in the presence of 4 /iM erythromycin
was also measured for comparative purposes ( ).
of the CPM-Ala-tRNAe^^A increased in the same way as
previously studied tRNAs (18; Table I). Conversely, CPM-Ala-
tRNA;Ala/AAA had a higher anisotropy when free in solution
(0.205) and a lower anisotropy when bound at the ribosomal P
site (0.310) in comparison to free (0.185) and P site-bound
(0.346) CPM-Ala-tRNA,,^^ (Table I). P site binding was
confirmed by adding puromycin which resulted in a large
decrease in the anisotropy of bound CPM-Ala-tRNAe
Ala/AAA (to
0.175) and CPM-Ala-tRNAjAla/AAA (to 0.183) as each CPM-
Ala-puromycin product was formed and subsequently released
from the ribosome (data not shown).
When deacylated tRNAPhe was prebound to the 70S
ribosomes to promote A site binding of CPM-Ala-tRNAi
Ala/AAA,
no change in the quantum yield, anisotropy or emission spectrum
was observed indicating that no binding had occurred (Table I).
This was confirmed by experiments demonstrating that, after pre-
binding of deacylated tRNAPhe, the CPM-Ala-tRNAjAla/AAA did
not remain with the ribosome fraction when the reaction
components were separated by gel filtration on Sephacryl S-300
(data not shown). Conversely, CPM-Ala-tRNAe
Ala/AAA appeared
to bind at the ribosomal A site as judged by increased anisotropy
(0.312) and quantum yield (0.472) (Table I). Typically less than
10% of this A site-bound CPM-Ala-tRNAe
Ala/AAA was reactive
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Table II. Polyalanine Synthesis after Prebinding Three Different N-blocked Aminoacyl-tRNAs



















Ac[l4C]aminoacyl-tRNA was used in the presence of nonradiative alanine to determine the number
of nascent chains initiated. [l4C]Alanine was used to measure pmol Ala incorporated into
polyalanine. The average length of nascent polyalanine is given by pmol Ala/pmol nascent chains
as described in Methods.
Table III. IF-2 Mediates the Binding of CPM-Ala-tRNAiAla/AAA to Ribosomes
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IF-2 and/or 30S ribosomal subunits were incubated with the fluorescent tRNA for 15 min at 37°C
with 6 mM Mg2+ present before measuring fluorescence. After each subsequent addition, the
reaction mixture was incubated 10 min at 37°C and then 15 min at 20°C (in the cuvette used for
fluorescence measurements) prior to reading the fluorescence. All reactions were carried out in a
final volume of 600 p\ as described in Methods. Following the addition of ribosomes, the Mg2 +
concentration was increased 9 mM (to give a final concentration of 15 mM) to allow for the
nonenzymatic binding of the fluorescent tRNAs. The anisotropy and quantum yield were then measured
again for comparative purposes.
The data suggest that the synthetic initiator tRNA has retained
the binding properties of natural tRNA^". These properties are
paralleled by fluorescence characteristics that differ from those
of the elongator Ala-tRNA.
Poly(U)-dependent translation
AcPhe-tRNA was prebound to poly(U)-programmed E.coli
ribosomes (in the presence of 15 mM Mg2+) to facilitate
polypeptide synthesis as outlined under Methods. Then
polyalanine synthesis was attempted with either tRNAe
Ala/AAA or
tRNA.Aia/AAA. Only t R N A ^ ^ supported poly(U)-dependent
polyalanine synthesis (Figure 2). Synthetic elongator tRNA-
dependent polyalanine synthesis was linear for more than 60 min
at 37°C (Figure 2) and for longer than 2 h at 20°C (data not
shown). Conversely, when tRNAj
Ala/AAA was used, polyalanine
synthesis was only slightly above background levels (Figure 2).
An interesting feature of polyalanine synthesis in this system is
that it is sensitive to inhibition by erythromycin (Figure 2). This
is in contrast to polyphenylalanine synthesis which is resistant
to erythromycin, presumably because of the extremely atypical
physical and chemical properties of this polypeptide (discussed
in 15). The synthesis of other synthetic nad natural polypeptides
is inhibited by erythromycin (22).
We then determined if AcAla-tRNAiAla/AAA or AcAla-
tRNAe
Ala/AAA could be nonenzymatically prebound to ribosomes
to facilitate polyalanine synthesis. Incorporation of alanine into
polyalanine from Ala-tRNAe
AJayAAA was similar whether AcAla-
tRNAe
Ala/AAA, AcAla-tRNAjAla/AAA or AcPhe-tRNA was
prebound to poly(U)-programmed 70S ribosomes (Table II). The
length of the nascent peptides produced was similar regardless
of the initiating tRNA (Table II). The important feature of these
data is that while tRNAjAla/AAA is not functional for peptide
elongation, it is able to bind at the ribosomal P site to allow
nonenzymatically-initiated peptide synthesis. It should be noted,
also, that polyalanine synthesis was inhibited by erythromycin,
regardless of the initiating acyl-tRNA (even AcPhe-tRNA; data
not shown).
IF-2 mediates the binding of CPM-Ala-tRNAjAla/AAA to
ribosomes
The ability of tRNA;Ala/AAA to function in enzymatic peptide
initiation was tested using purified E.coli initiation factor 2 (IF-2)
to bind the tRNA to 30S and 70S ribosomes (in 6 mM Mg2+).
IF-2 facilitated binding of C P M - A l a - t R N A ^ ^ to 30S
subunits as judged by increased anisotropy and quantum yield
(Table III). When 50S subunits were then added to the reaction
mixture, over 80% of the CPM-Ala-tRNAi
Ala/AAA was bound to
the 70S ribosomes in 6 mM Mg2+ as indicated by increased
fluorescence anisotropy (Table HI). Only a slight further increase
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increased to 15 mM to mediate the nonenzymatic binding of the
tRNA as discussed above (Table III). With poly(U), at 6 mM
Mg2 + , CPM-Ala-tRNAiAlaMAA did not bind to 30S ribosomal
subunits in the absence of IF-2 and only poorly to 70S ribosomes
(Table HI). Only after increasing the Mg2+ to 15 mM did the
initiator tRNA bind to poly(U)-programmed ribosomes in the
absence of IF-2 (Table HI). These data indicate that IF-2 mediates
the binding of CPM-Ala-tRNAi
Ala/AAA to 30S ribosomal subunits
or to 70S ribosomes in 6 mM Mg2+.
CPM-Ala-tRNAe
Ala/AAA, in contrast, did not bind to 30S or
70S ribosomes in 6 mM Mg2+ in the presence or absence of
IF-2 (Table III); however, in each case it did bind upon increasing
the Mg2+ concentration to 15 mM. At the high Mg2+
concentration, the fluorescence anisotropy and quantum yield of
CPM-Ala-tRNAeAlaMAA increased to the values previously
observed for ribosome binding (see Table I).
The effect of ribosome binding and the subsequent binding
of erythromycin or sparsomycin with puromycin on the
fluorescence of the synthetic initiator and elongator tRNAs
Fluorescence from the coumarin moiety of CPM is very sensitive
to hydrophobicity, charge, and other factors in the immediate
vicinity of the probe. Entrance into a region of increased
hydrophobicity typically results in a blue shift of the emission
spectrum of CPM accompanied by an increase in fluorescence
intensity, while a red shift and decreased intensity are usually
indicative of entrance into a more polar environment. This
environmental sensitivity was used to compare the two CPM-
Ala-tRNAs under different conditions. The fluorescence emission
spectra of CPM-Ala-tRNAe
Ala/AAA and CPM-Ala-tRNAiAla/AAA
were measured when the tRNAs were free in solution, bound
to poly(U)-programmed ribosomes, bound to ribosomes
simultaneously with erythromycin and bound to ribosomes
simultaneously with sparsomycin and puromycin (Figure 3A and
B). Sparsomycin has been shown in this laboratory to bind to
70S ribosomes and inhibit puromycin reactivity with P site-bound
N-acyl-Phe-tRNA without preventing the binding of puromycin
(Odom and Hardesty, manuscript in preparation).
The intensity of the emission spectrum of CPM-AJa-
tRNAe
Ala/AAA is increased and accompanied by a considerable
blue shift (6 nm) upon binding to ribosomes (Figure 3A). The
emission of CPM-Ala-tRNAjAla/AAA undergoes a similar
although somewhat smaller increase in fluorescence intensity
upon binding to ribosomes (Figure 3B), accompanied by a
smaller blue shift (3 nm). When erythromycin was bound to
ribosomes already containing CPM-Ala-tRNAe
Ala/AAA, a 15%
increase in the fluorescence intensity was observed, accompanied
by a further 3 nm blue shift in the emission maximum
(Figure 3A). Erythromycin resulted in only a 3% increase in the
relative intensity of bound CPM-Ala-tRNAi
Ala/AAA accompanied
by a 2 nm blue shift in the emission spectrum (Figure 3B). These
observations suggest that the CPM-Ala moiety on the initiator
tRNA is in a somewhat different position on the ribosome relative
to the bound erythromycin. The fluorescence of each tRNA (after
binding to poly(U)-programmed ribosomes) was also examined
following the sequential addition of sparsomycin and puromycin.
Sparsomycin binding had little effect on the emission spectrum
of either fluorescent tRNA (data not shown). Sparsomycin,
however, is an inhibitor of puromycin reactivity, and allows for
examination of the effect of puromycin binding on the
fluorescence of each tRNA (Figure 3A and B). Puromycin
binding resulted in a 26% increase in the fluorescence intensity













430 450 470 490 510
Wavelength, nm
530
Figure 3. The emission spectra of free and ribosome-bound elongator and initiator
CPM-Ala-tRNAAla/AAA. The emission spectrum of CPM-Ala-tRNAe
Ala/AAA
(panel A) and CPM-Ala-tRNAiAla/AAA (panel B) (30 pmol each) was measured
as described in Methods. Measurements were in a final volume of 600 ji\ for
the free ( ) and ribosome-bound ( ) tRNAs. Ribosomes were present at
0.5 nM. After the ribosomes were added, the reaction mixtures were incubated
for 15 min at 37°C. Fluorescence measurements were carried out at 20°C with
an excitation wavelength of 385 nm. After the measurements were complete,
erythromycin was added to a final concentration of 4 /iM and the effect of
erythromycin binding on the spectrum of each ribosome-bound tRNA was
monitored ( • • ) • 'n another experiment the emission spectrum of each tRNA
was measured after ribosome binding. Sparsomycin was subsequently added (final
concentration = 5 pM). The emission spectrum was taken. Then puromycin was
added to give a concentration of 0.5 mM. The emission spectrum was again
measured (- • •- • •)• After measuring the emission spectrum in the presence of
puromycin, the fluorescence anisotropy of each sample was measured to assure
that no drop in anisotropy had occurred which would indicate puromycin reactivity.
of bound CPM-Ala-tRNA,,Ala/AAA with a 4 nm blue shift in the
emission maximum (Figure 3A). No change in anisotropy was
observed, which confirms sparsomycin inhibited puromycin
reactivity. Under identical conditions, puromycin binding resulted
in only a 6% increase in the fluorescence of bound CPM-Ala-
tRNAi
Ala/AAA with a 4 nm blue shift (Figure 3B).
The results with erythromycin and sparsomycin/puromycin
support the conclusion that the CPM-Ala portion of this initiator
tRNA is held in a different position on the ribosome than is the
same portion of the elongator tRNA. An interesting feature of
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AcAla-tRNA is inhibited by erythromycin and each N-acyl-tRNA
is puromycin-reactive (in the absence of sparsomycin) when
bound in the ribosomal P site. This suggests the CPM-AJa
portions of the two synthetic tRNAs are held differently with
respect to the binding sites of erythromycin and puromycin
without any obvious effect on the function of either antibiotic.
DISCUSSION
We have generated analogues of E.coli initiator tRNAMel and
tRNA^ that can be enzymatically aminoacylated with alanine.
Alanine was chosen because of the well characterized
aminoacylation requirements of tRNA^3 (23), and both tRNAs
were given AAA anticodons to promote recognition by poly(U).
Although GAA is the naturally-occurring anticodon for UUU and
UUC codons, we chose not to depend upon wobble for the
recognition of poly(U) by the two synthetic alanyl tRNAs. The
results presented above indicate tRNAjAla/AAA has initiator
function, and only tRNAe
Ala/AAA functioned in peptide
elongation.
The fluorescence properties of a CPM residue on the a-amino
group of these two aminoacylated tRNAs reflect the local
environment around the fluorophore when the tRNAs are either
free in solution or bound to ribosomes. CPM-Ala-tRNAc
Ala/AAA
binds to 70S ribosomes with many of the same properties we
have previously reported for CPM-Phe-tRNA (18) and synthetic
CPM-Ser-tRNASer/AAA (11). For CPM-Ala-tRNAiAla/AAA,
however, the fluorescence anisotropy data indicate that the
fluorophore is held more rigidly than that of its elongator
counterpart when each is free in solution. Conversely, the
fluorophore on the initiator tRNA analogue appears to be able
to move more freely than the same probe on the elongator tRNA
when bound to 70S ribosomes. In addition, although each
fluorescent tRNA binds to the ribosomal 'P site', each responds
differently to the subsequent binding of erythromycin. Considered
together these results suggest that the CPM probe and presumably
the alanine to which it is linked are not in identical positions when
the two tRNAs are in the ribosomal 'P site'. This difference in
binding relative to the binding site of erythromycin does not
prevent the antibiotic from inhibiting polyalanine synthesis started
after prebinding N-blocked elongator Ala-tRNA, initiator Ala-
tRNA, or Phe-tRNA.
We propose that the different fluorescence properties reported
here may be general features of elongator and initiator tRNAs
and that they are a direct result of the special sequence and
structural features of these tRNAs. The results also suggest that
neither methionine nor the AUG codon are uniquely required
for peptide initiation with IF-2. Indeed, initiator tRNAs mutated
to recognize UUC and GUC codons and aminoacylated with
phenylalanine and valine, respectively, have been shown to
initiate enzymatically active /3-galactosidase in vivo when the
mRNA contains the appropriate codon at the initiator codon
position (24). In a similar study, initiation of active
chloramphenicol acetyltransferase can occur from an amber (UA-
G) codon, probably with glutamine, when an initiator tRNA
altered to recognize the initiation amber codon is present (25).
ABBREVIATIONS
Poly(U), polyuridylic acid; Acaa-tRNA, aminoacyl-tRNA which
has been acetylated on its a-amino group; tRNAe
Ala/AAA, a
synthetic elongator tRNA which has an AAA anticodon and is
aminoacylated with alanine; tRNAjAla/AAA, a synthetic initiator
tRNA which has an AAA anticodon and is aminoacylated with
alanine; tRNASer/AAA, a synthetic elongator tRNA which has an
AAA anticodon and is aminoacylated with serine; CPM-Ala-
tRNAe
Ala/AAA and CPM-Ala-tRNAjAla/AAA, elongator and
initiator synthetic tRNAAla/AAA, respectively, which has been
aminoacylated, mercaptoacetylated at its amino group and then
reacted with CPM; CPM, 3-(4-maleimidophenyl)-7-diethyl-
amino-4-methylcoumarin; IF-2, prokaryotic translation initiation
factor 2; PCR, polymerase chain reaction.
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